Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non–Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013-Reference-Cited by-同舟云学术

Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non–Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013

Published:2022-03-18 Issue:3 Volume:5 Page:e223050
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Bree Kelly K.¹,Shan Yong²,Hensley Patrick J.¹,Lobo Niyati¹,Hu Chengrui²,Tyler Douglas S.³,Chamie Karim⁴,Kamat Ashish M.¹,Williams Stephen B.²

Affiliation:

1. Department of Urology, University of Texas MD Anderson Cancer Center, Houston

2. Division of Urology, Department of Surgery, University of Texas Medical Branch, Galveston

3. Department of Surgery, University of Texas Medical Branch, Galveston

4. Department of Urology, University of California, Los Angeles, Los Angeles

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2790255/bree_2022_oi_220120_1647021122.74839.pdf

Reference41 articles.

1. Cancer statistics, 2021.;Siegel;CA Cancer J Clin,2021

2. Bladder cancer.;Kamat;Lancet,2016

3. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome.;Herr;J Urol,2000

4. Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG).;Matulay;BJU Int,2020

5. Diagnosis and treatment of non–muscle invasive bladder cancer: AUA/SUO guideline.;Chang;J Urol,2016

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and management of prostatic urethra recurrence in a cohort of 21 patients who received BCG induction for non-muscle invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2024-09

2. Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG);European Urology Oncology;2024-08

3. Financial Distress in Genitourinary Cancer: Insights From CDC National Health Interview Survey;JCO Oncology Practice;2024-07-15

4. Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment?;BJU International;2024-05-22

5. The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer;International Journal of Molecular Sciences;2024-02-11